March 25, 2026

Artica Therapeutics appoints Jason Witherington as Chief Scientific Officer

November 27, 2024

Artica Therapeutics announces establishment of scientific advisory board

March 21, 2024

Artica Therapeutics appoints Piet Wigerinck to its Board of Directors

November 2, 2023

Artica Therapeutics closes €12M seed investment to develop covalent therapeutics for autoimmune and inflammatory disorders

April 18, 2023

Artica Therapeutics successfully secures Mibiton financial lease funding